Discerning the difference between some benign lesions and early stage breast cancer is a particularly challenging area of pathology, according to medical records and interviews with doctors and patients.

Diagnosing D.C.I.S. “is a 30-year history of confusion, differences of opinion and under- and overtreatment,” said Dr. Shahla Masood, the head of pathology at the University of Florida College of Medicine in Jacksonville. “There are studies that show that diagnosing these borderline breast lesions occasionally comes down to the flip of a coin.”

http://www.nytimes.com/2010/07/20/health/20cancer.html?_r=1&src=me&ref=homepage

This entry was posted on Tuesday, July 20th, 2010 at 1:54 pm. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.